Intravenous Lidocaine for Refractory Pain in Patients With Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis: A Multicenter Prospective Nonrandomized Pilot Study

Intravenous lidocaine in patients with painful PDAC and CP did not show an overall clinically relevant reduction of pain. However, this pilot study shows that the treatment is feasible in this patient group and had a positive effect in a third of patients which lasted up to a month with only minor side effects. To prove or exclude the efficacy of intravenous lidocaine, the study should be performed in a study with a greater sample size and less heterogeneous patient group.

Authors

Institutions

Publication Details

Journal
Clinical and Translational Gastroenterology
Published
2024-08-19
DOI
https://doi.org/10.14309/ctg.0000000000000760
Citations
4
Primary Topic
Pain Management and Opioid Use
Type
article
Field-Weighted Citation Impact
2.57
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Intravenous Lidocaine for Refractory Pain in Patients With Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis: A Multicenter Prospective Nonrandomized Pilot Study

Rogier P. Voermans, Casper H.J. van Eijck, Werner ten Hoope, Marc G. Besselink et al.
4 citations
Clinical and Translational Gastroenterology
Pain Management and Opioid Use
2.57
article

Intravenous Lidocaine for Refractory Pain in Patients With Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis: A Multicenter Prospective Nonrandomized Pilot Study

Rogier P. Voermans, Casper H.J. van Eijck, Werner ten Hoope, Marc G. Besselink, Stefan A.W. Bouwense, Henk J. van Kranen, Jan Willem Kallewaard, Marja A. Boermeester, Monique A. H. Steegers, Judith de Vos‐Geelen, Charlotte L. van Veldhuisen, Olivier R. Busch, Marco J. Bruno, Bert A. Bonsing, Jan H.M. Van Zundert, Niels C.J. Schellekens, Markus W. Hollmann, Simone Augustinus, Matthanja Bieze, Marieke Niesters, Johanna W. Wilmink
article en
4 citations

Abstract

Intravenous lidocaine in patients with painful PDAC and CP did not show an overall clinically relevant reduction of pain. However, this pilot study shows that the treatment is feasible in this patient group and had a positive effect in a third of patients which lasted up to a month with only minor side effects. To prove or exclude the efficacy of intravenous lidocaine, the study should be performed in a study with a greater sample size and less heterogeneous patient group.

Clinical and Translational GastroenterologyVol. 15(9)
University of Toronto (CA), Leiden University Medical Center (NL), Maastricht University Medical Centre (NL), Toronto General Hospital (CA), Erasmus MC (NL), Maastricht University (NL), Ziekenhuis Oost-Limburg (BE), Metropolitan University (BD), Amsterdam University Medical Centers (NL), Rijnstate Hospital (NL), Cancer Center Amsterdam (NL), University of Amsterdam (NL)
Good health and well-being
Openalex Percentile: Top 11%
Pain Management and Opioid Use
2.57
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.